DR. J THADDEUS BECK M.D. F.A.C.P. NPI 1952372120

NPI Details

DR. J Thaddeus Beck, M.D., F.A.C.P. is a hematology and oncology internal medicine in Fayetteville, AR with 41 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. J Thaddeus Beck, M.D., F.A.C.P. NPI is 1952372120. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:1985

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1952372120 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Phosphate level (HCPCS:84100)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Bilirubin level, direct (HCPCS:82248)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of chest with contrast (HCPCS:71260)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Unclassified drugs (HCPCS:J3490)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood test, clotting time (HCPCS:85610)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Ct scan of chest without contrast (HCPCS:71250)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Blood creatinine level (HCPCS:82565)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• X-ray of chest, 2 views (HCPCS:71046)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Drawing of blood for a medical problem (HCPCS:99195)
• Vitamin d-3 level (HCPCS:82306)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Heart muscle strain imaging (HCPCS:93356)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)

The enumeration date for this NPI number is 1/27/2006 and was last updated on 3/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.